New Research Reveals Michigan Hospitals Are Exploiting a Program Meant to Make Medicines Affordable for Low-Income Patients
New research reveals that Michigan hospitals are making significant profits off a program designed to help low-income patients access affordable medicine without delivering community benefits.
Many 340B Disproportionate Share Hospitals Fail to Reinvest in Patient Care
A new analysis of 340B hospital data found that the number of Disproportionate Share Hospitals (DSHs) participating in the 340B Drug Pricing Program1 has surged more than sixfold, rising 565% from 2004 to 2023, with little evidence of commensurate growth in benefit to vulnerable populations. Yet, following 340B enrollment, DSHs’ financial investments, including stocks, bonds and other financial instruments, soared.
